Micropulse transscleral laser therapy for secondary angle-closure glaucoma in nanophthalmos: a case report  

作　　者：Ping Yu Bai-Yu Hu Yu He Lin Jing Han-Ying Fan Jing Shu Liu-Zhi Zeng 

机构地区：[1]Chengdu First People’s Hospital,Chengdu 610095,Sichuan Province,China [2]Eye School of Chengdu University of TCM,Chengdu 610075,Sichuan Province,China

出　　处：《International Journal of Ophthalmology(English edition)》2024年第7期1381-1384,共4页国际眼科杂志（英文版）

摘　　要：Dear Editor,The choice of surgical intervention for nanophthalmos patients with secondary angle-closure glaucoma poses a challenging decision for ophthalmologists.Because nanophthalmos patients who have undergone filtration surgery or other intraocular procedures are more susceptible to severe complications,including choroidal effusion,malignant glaucoma,and explosive choroidal hemorrhage,all of which can lead to vision loss[1].This dilemma is particularly pronounced in patients with shorter axial lengths.Micropulse transscleral laser therapy(M-TLT),also known as micropulse transscleral cyclophotocoagulation(MP-TSCPC),is a nonincisional laser therapy surgery for glaucoma[2].In 2015,Golan and Kurtz[3]were the first to report four patients with secondary angle-closure glaucoma in nanophthalmos with axial lengths ranging between 17 and 19 mm(mean 18 mm)who were successfully treated with M-TLT,and choroidal detachment was observed in all patients(recovery spontaneously in two patients and recovery after systemic steroid treatment in the other two),of which two had a slight decrease in visual acuity.

关 键 词：GLAUCOMA SURGERY CLOSURE 

分 类 号：R775[医药卫生—眼科]